Centaur Pharmaceuticals

Discovery of a novel topical solution WoxHeal for the treatment of Diabetic Foot Ulcer by Centaur Pharma for the first time in the world

Discovery of a novel topical solution WoxHeal for the treatment of Diabetic Foot Ulcer by Centaur Pharma for the first time in the world

25% people with Diabetes develop a Diabetic Foot Ulcer 1 in 5 people developing severe infection undergo foot amputation Developed with German technology partner – CytoTools AG Will help save millions of foot amputating happening in India and the world-over Mumbai [India] : Centaur Pharmaceuticals announced the launch of a New Chemical Entity (NCE) – WOXheal® – for the first time in the world. With its dual mechanism of action, WOXheal® is a unique product in the treatment of Diabetic Foot ulcers, and it will save millions of Diabetics who have to undergo foot amputation globally. WHO predicts that there…
Read More